News Highlights : Top Company News of the Day - Tuesday at 11 PM ET
Merck Nears $1.3 Billion Deal for Eye-Drug Company EyeBio Such an acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the multibillion-dollar eye-drug market....
Source: marketscreener.com